Suppr超能文献

容量治疗和己酮可可碱输注对创伤患者循环黏附分子的影响。

The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients.

作者信息

Boldt J, Heesen M, Padberg W, Martin K, Hempelmann G

机构信息

Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Germany.

出版信息

Anaesthesia. 1996 Jun;51(6):529-35. doi: 10.1111/j.1365-2044.1996.tb12557.x.

Abstract

Adhesion molecules appear to play a pivotal role in tissue damage secondary to the inflammatory process. Besides neutrophil- and endothelial-bound adhesion molecules, soluble forms have been detected in the circulating blood. They seem to be good markers of endothelial damage, but they may also have other biological functions. Plasma concentrations of soluble adhesion molecules (endothelial leucocyte adhesion molecules (sELAM-1), intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), and granule membrane protein 140 (sGMP-140) were serially measured over 5 days by enzyme-linked immunosorbent assays (ELISA) in 45 consecutive trauma patients. These received, by random allocation, only either hydroxyethylstarch solution 10% (mean molecular weight 200,000 daltons) (n = 15) or human albumin 20% (n = 15) for volume therapy. Another 15 patients without defined volume therapy received pentoxifylline continuously (1.2 mg.kg-1.h-1). Measurements were carried out on the day of admission to the intensive care unit (baseline) and during the next 5 days. At baseline, plasma concentrations of all adhesion molecules were similar in all groups. In the hydroxyethyl starch group, sELAM-1 and sICAM-1 concentrations decreased significantly (p < 0.05) reaching normal values during the study period whereas the mean (SD) values increased in the pentoxifylline group (sELAM-1: 71.1 (16.7) to 91.6 (17.8) ng.ml-1) and the albumin group (sICAM-1: 400 (81) to 749 (101) ng.ml-1) (p < 0.05). sVCAM-1 increased outside the normal range only in the human albumin group (to 760 +/- 69 ng.ml-1) (p < 0.05). sGMP-140 plasma concentration increased only in those receiving albumin (432 (85) to 550 (93) ng.ml-1) and this was significantly different to the other groups (p < 0.05). None of the other haemodynamic or laboratory factors could be correlated with plasma concentrations of the adhesion molecules. We conclude that volume therapy with hydroxyethyl starch resulted in a decrease in circulating adhesion molecules in our trauma patients. In contrast, volume therapy with albumin did not exert this effect. Continuous infusion of pentoxifylline did not have a beneficial modulating action on circulating adhesion molecules.

摘要

黏附分子似乎在继发于炎症过程的组织损伤中起关键作用。除了与中性粒细胞和内皮细胞结合的黏附分子外,循环血液中还检测到了可溶性形式。它们似乎是内皮损伤的良好标志物,但也可能具有其他生物学功能。通过酶联免疫吸附测定(ELISA)对45例连续创伤患者在5天内连续测量血浆中可溶性黏附分子(内皮白细胞黏附分子(sELAM-1)、细胞间黏附分子-1(sICAM-1)、血管细胞黏附分子-1(sVCAM-1)和颗粒膜蛋白140(sGMP-140))的浓度。这些患者通过随机分配,仅接受10%羟乙基淀粉溶液(平均分子量200,000道尔顿)(n = 15)或20%人白蛋白(n = 15)进行容量治疗。另外15例未进行明确容量治疗的患者持续接受己酮可可碱(1.2mg·kg-1·h-1)治疗。在重症监护病房入院当天(基线)及随后5天进行测量。基线时,所有组中所有黏附分子的血浆浓度相似。在羟乙基淀粉组中,sELAM-1和sICAM-1浓度显著降低(p < 0.05),在研究期间达到正常水平,而在己酮可可碱组(sELAM-1:71.1(16.7)至91.6(17.8)ng/ml-1)和白蛋白组(sICAM-1:400(81)至749(101)ng/ml-1)中平均值(标准差)升高(p < 0.05)。sVCAM-1仅在人白蛋白组中升高至正常范围之外(至760±69 ng/ml-1)(p < 0.05)。sGMP-140血浆浓度仅在接受白蛋白治疗的患者中升高(432(85)至550(93)ng/ml-1),且与其他组有显著差异(p < 0.05)。其他血流动力学或实验室因素均与黏附分子的血浆浓度无关。我们得出结论,在我们的创伤患者中,羟乙基淀粉容量治疗导致循环黏附分子减少。相比之下,白蛋白容量治疗未产生此效果。持续输注己酮可可碱对循环黏附分子没有有益的调节作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验